The multichain interleukin-2-receptor: A target for immunotherapy of patients with adult T-cell leukemia, autoimmune disorders and individuals receiving allografts
- 1 December 1988
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 1 (6) , 641-653
- https://doi.org/10.1016/0896-8411(88)90055-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2The Lancet, 1987
- Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggeringCell, 1987
- T Cell Activation Antigens: Therapeutic ImplicationsImmunological Investigations, 1987
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987
- Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.The Journal of Experimental Medicine, 1985
- Circulating Activated Suppressor T Lymphocytes in Aplastic AnemiaNew England Journal of Medicine, 1985
- Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.Journal of Clinical Investigation, 1984
- Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.Journal of Clinical Investigation, 1984
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976